Pure Global AI
MS Décret

Décret n°2016-28 du 16 février 2016

Marge bénéficiaire de la CAMEC pour les médicaments de monopole, les médicaments génériques, matériels et consommables médicaux
MauritaniaMinistère de la SantéGeneralCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

Décret n°2016-28 du 16 février 2016 is the official MS identifier for “Marge bénéficiaire de la CAMEC pour les médicaments de monopole, les médicaments génériques, matériels et consommables médicaux”. Décret n°2016-28 du 16 février 2016 is the official identifier MS uses for this instrument.

Instrument
Décret
Full name
Décret n°2016-28 du 16 février 2016
Category
General
Source links
Source publication
French
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
2016-03-30
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Marge bénéficiaire de la CAMEC pour les médicaments de monopole, les médicaments génériques, matériels et consommables médicaux

Complete three-article historical decree fixing CAMEC’s margin at seven percent of cost for the named medicines, medical equipment and consumables. Its repeal clause concerns contrary earlier provisions and does not name repeal of the whole 2010 CAMEC decree. The percentage is CAMEC-specific and is not a general device registration fee, a universal IVD rule or a verified current 2026 rate. Later amendments and current applicability remain unverified.

Décret n°2016-28 du 16 février 2016 is the official identifier MS uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.